This is a medicine used to treat too much iron in the body. It works by binding to the iron and helping the body remove it. It's often given through an IV (intravenous) line.
Every report comes from a Lived member, sent anonymously.
Have you tried Desferal (Deferoxamine) for Iron Overload?
Deferoxamine, sold under the brand name Desferal and as generic deferoxamine mesylate, is an injectable medicine that removes excess iron from the body. Its main long-term use is for iron overload caused by repeated blood transfusions in people with chronic anemias such as thalassemia or sickle cell disease. Transfused blood brings iron with it, and over time that iron builds up in the heart, liver and hormone-producing glands, where it can cause serious damage. Removing it with a medicine like deferoxamine is called iron chelation therapy. It is also used in the hospital for acute iron poisoning, alongside other emergency treatment rather than in place of it. Deferoxamine is not used for hereditary hemochromatosis, the inherited form of iron overload, because regularly removing blood (phlebotomy) is the standard treatment there. For transfusional iron overload, two oral chelators, deferasirox (Exjade, Jadenu) and deferiprone (Ferriprox), are now widely used, so deferoxamine is one of several options. It is sometimes combined with deferiprone.
Deferoxamine is a chelator, a molecule that grabs onto a metal and holds it tightly. It binds iron held in the body's storage proteins, ferritin and hemosiderin, and forms a stable compound that keeps that iron from taking part in further chemical reactions. It does not pull iron out of hemoglobin, so it does not take iron away from working red blood cells. The iron-deferoxamine compound dissolves in water and leaves the body mostly through the kidneys, which is why urine can look reddish during treatment. Some also leaves through bile into the stool.
Deferoxamine comes as a powder in a vial that is mixed with sterile water before use. It is not taken by mouth. For long-term iron overload, it is usually given as a slow infusion under the skin from a small portable pump, running over 8 to 12 hours, 5 to 7 times a week. Many people wear the pump overnight, which lets treatment happen at home. It is not designed to be given as a quick injection under the skin. It can also run through an existing intravenous line, or less often be injected into a muscle. The dose depends on body weight and on how much iron has built up, judged partly by ferritin, a blood test that reflects the body's iron stores. A higher ferritin generally means more stored iron and a need for more intensive treatment. As ferritin falls, especially below about 1,000 ng/mL, the risk of side effects rises, so the prescriber may lower the dose. For acute iron poisoning, hospital staff give it as an injection into a muscle, or by slow intravenous drip in someone in shock. It is always infused slowly, because giving it quickly into a vein can cause a sharp drop in blood pressure and allergic reactions.
Reactions where the needle goes in are the most common problem: pain, burning, swelling, redness, itching or a firm lump under the skin. Some people also have fever, headache, joint or muscle aches or nausea along with a site reaction. Reddish urine is expected and reflects the iron being removed. Deferoxamine can cause dizziness, so it is sensible not to drive until you know how it affects you. With long-term use, particularly at higher doses or once iron stores have dropped low, deferoxamine can affect vision and hearing. Changes include blurred vision, poorer night or color vision, cataracts, ringing in the ears and loss of high-pitched hearing. These problems are more likely to reverse when they are caught early, so report any change in sight or hearing to the care team promptly rather than waiting for the next scheduled test. Kidney strain is another possible effect, which is why kidney blood tests are part of routine monitoring. Rarely, excessively high intravenous doses have caused a serious lung injury called acute respiratory distress syndrome, one reason recommended doses are not exceeded. Severe allergic reactions are uncommon and happen mostly when the drug is given too quickly into a vein. Swelling of the face or throat, trouble breathing, widespread hives or feeling faint during or after a dose needs emergency care: call 911.
Deferoxamine is not used in people with severe kidney disease or who make little or no urine, because both the drug and the iron it carries leave the body through the kidneys. Deferoxamine raises the risk of two uncommon but serious infections: Yersinia, a type of bacterial infection, and mucormycosis, a dangerous fungal infection that has sometimes been fatal. Contact the care team promptly about fever or other signs of a new infection. If one of these infections is suspected, deferoxamine is paused while it is treated. People with iron overload are often low in vitamin C, and a small supplement can help deferoxamine remove more iron. High doses, more than 500 mg a day in adults, have caused heart problems in people with severe iron overload, which improved once the vitamin C was stopped. Vitamin C should be taken only as the prescriber directs: not at all with heart failure, not until after the first month of regular treatment, and no more than 200 mg a day for adults, split into smaller doses (children use less). Taking deferoxamine with prochlorperazine, an anti-nausea medicine, can cause a temporary loss of consciousness. Deferoxamine also distorts gallium-67 scans, a type of nuclear imaging, so it is stopped 48 hours beforehand. In animal studies deferoxamine harmed developing offspring, and there is no human pregnancy data. Effective contraception is advised during treatment and for one month after the last dose, for women who could become pregnant and for men whose partners could. Anyone pregnant or planning pregnancy should discuss the balance of risks with the care team. Breastfeeding is not advised during treatment or for one week after the last dose.
Deferoxamine lowers iron gradually, and for transfusional iron overload it is a long-term treatment. Progress is followed with regular ferritin blood tests and, in some cases, MRI (magnetic resonance imaging) scans that estimate how much iron is in the heart. The dose is adjusted as iron levels change. The routine is demanding: many hours on a pump several times a week, plus soreness at infusion sites. Reviews of chelation therapy note that these demands and side effects can wear on daily life and make it hard to keep up with treatment. If the schedule is not working, raise it with the care team, since oral chelators and combinations are alternatives. Ongoing monitoring includes periodic eye exams and hearing tests, kidney blood tests and, for children, a height and weight check every 3 months, because high doses combined with low iron stores can slow growth. Safety and effectiveness have not been established in children under 3.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Desferal (Deferoxamine), what you've noticed, or ask the community a question.